These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8215237)

  • 1. Importance of exogenous cholesterol in diabetic rats: effects of treatment with insulin or with an acyl-CoA:cholesterol acyltransferase inhibitor.
    Maechler P; Wollheim CB; Bentzen CL; Niesor E
    Ann Nutr Metab; 1993; 37(4):199-209. PubMed ID: 8215237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the intestinal acyl-CoA:cholesterol acyltransferase activity in the hyperresponse of diabetic rats to dietary cholesterol.
    Maechler P; Wollheim CB; Bentzen CL; Niesor E
    J Lipid Res; 1992 Oct; 33(10):1475-84. PubMed ID: 1431572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
    Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
    Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
    Adameová A; Kuzelová M; Faberová V; Svec P
    Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of FR145237, an acyl-CoA:cholesterol acyltransferase inhibitor, on diet-induced hypercholesterolemia in diabetic rats.
    Sakuma Y; Hagihara H; Nagayoshi A; Ohne K; Mutoh S; Ito Y; Nakahara K; Notsu Y; Okuhara M
    Life Sci; 1997; 60(6):351-6. PubMed ID: 9031680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
    Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
    J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
    Krause BR; Anderson M; Bisgaier CL; Bocan T; Bousley R; DeHart P; Essenburg A; Hamelehle K; Homan R; Kieft K
    J Lipid Res; 1993 Feb; 34(2):279-94. PubMed ID: 8429262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-coenzyme A:cholesterol acyltransferase-2 (ACAT-2) is responsible for elevated intestinal ACAT activity in diabetic rats.
    Hori M; Satoh M; Furukawa K; Sakamoto Y; Hakamata H; Komohara Y; Takeya M; Sasaki Y; Miyazaki A; Horiuchi S
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1689-95. PubMed ID: 15242859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
    Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
    Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the ACAT inhibitor CL 277,082 on apolipoprotein B48 transport in mesenteric lymph and on plasma clearance of chylomicrons and remnants.
    Martins IJ; Mortimer BC; Redgrave TG
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):211-6. PubMed ID: 9012658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dehulled adlay on plasma glucose and lipid concentrations in streptozotocin-induced diabetic rats fed a diet enriched in cholesterol.
    Yeh PH; Chiang W; Chiang MT
    Int J Vitam Nutr Res; 2006 Sep; 76(5):299-305. PubMed ID: 17245668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of hyperinsulinemia on acyl-CoA:cholesterol acyltransferase activity in the liver and intestine of the rat.
    Yang LY; Kuksis A; Steiner G
    Atherosclerosis; 1994 May; 107(1):25-34. PubMed ID: 7945556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys.
    Marzetta CA; Savoy YE; Freeman AM; Long CA; Pettini JL; Hagar RE; Inskeep PB; Davis K; Stucchi AF; Nicolosi RJ
    J Lipid Res; 1994 Oct; 35(10):1829-38. PubMed ID: 7852860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activity.
    Sliskovic DR; Krause BR; Picard JA; Anderson M; Bousley RF; Hamelehle KL; Homan R; Julian TN; Rashidbaigi ZA; Stanfield RL
    J Med Chem; 1994 Mar; 37(5):560-2. PubMed ID: 8126693
    [No Abstract]   [Full Text] [Related]  

  • 19. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity.
    Kusunoki J; Aragane K; Kitamine T; Kozono H; Kano K; Fujinami K; Kojima K; Chiwata T; Sekine Y
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):171-8. PubMed ID: 10634814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.